Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 123
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
PT384 – Vital Psychedelic Conversations
Adapting to the Squeeze: Spending Trends, Slimming Pipelines, M&A and Partnerships...
Psychedelic Investor Pulse Survey – Q4 2022
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2023
Small Pharma Reports Fiscal Third Quarter 2023 Highlights
Hebrew University’ Yissum and Israeli Biotech Clearmind Medicine’s Psychedelic-Derived Obesity Treatment...
Small Pharma Reports Positive Top-line Results from Phase IIa Trial of...
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
Small Pharma To Announce Results of SPL026 Phase IIa Trial for...
Diamond Therapeutics Announces Health Canada Approval of Phase 2 Clinical Trial...
Load more
